Schering Temodar Data Show Long-Term Survival Rates Improve Fourfold Over Radiation Alone
This article was originally published in The Pink Sheet Daily
Executive Summary
Survival benefit of Temodar and radiation in glioblastoma patients was 12.1 percent in year four versus 3 percent with radiation alone.